Of all the supplements marketed for stomach health, zinc carnosine is the one with the most legitimate clinical evidence behind it. It’s been used as a gastric ulcer treatment in Japan since the 1990s, has multiple randomized controlled trials, and its mechanism of action is well-characterized. Here’s what the research actually shows – and where the honest limits are.
Zinc carnosine (ZnC, branded as PepZin GI) is a chelated complex of zinc and the dipeptide L-carnosine developed in Japan and approved as a pharmaceutical agent for gastric ulcers under the name Polaprezinc (Promac). It works through multiple mechanisms: zinc supports mucosal repair and metallothionein production; carnosine has antioxidant and anti-inflammatory activity at the gastric mucosa; the chelated complex has extended mucosal contact time compared to isolated zinc or carnosine; and ZnC inhibits H. pylori growth in vitro. Multiple clinical RCTs in Japan confirm efficacy for gastric ulcer healing comparable to standard treatment. It is one of the most evidence-backed natural/nutraceutical compounds for gastric mucosal protection.
- Zinc carnosine’s gastroprotective superiority over its individual components stems from the chelated structure remaining intact in the stomach and adhering to ulcerated mucosa – studies show 10x longer mucosal contact time for ZnC vs. zinc or carnosine alone, enabling more sustained local activity.
- Six documented mechanisms: mucosal repair via zinc-dependent matrix metalloprotease regulation; anti-oxidant activity (carnosine scavenges reactive oxygen species and lipid peroxidation products); anti-inflammatory (suppresses IL-8, NF-?B); H. pylori inhibition in vitro; heat shock protein induction (cellular cytoprotection); and metallothionein upregulation (zinc-binding proteins protecting cells from oxidative injury).
- A landmark challenge trial (Mahmood et al., Gut 2007) randomized 31 healthy volunteers to ibuprofen with/without PepZin GI – ZnC supplementation significantly attenuated NSAID-induced intestinal permeability increase and small intestinal inflammation, a unique finding with implications for NSAID-related gastropathy.
- Therapeutic dose: 75 mg ZnC twice daily (as used in Japanese pharmaceutical trials) = approximately 32 mg elemental zinc per day – close to the tolerable upper limit (40 mg/day). At this dose, copper supplementation (1-2 mg/day) is recommended to offset zinc-induced copper depletion over long-term use.
- ZnC is particularly suitable for: NSAID users, individuals with H. pylori-negative gastritis, gastric ulcer history or recovery, protein pump inhibitor users seeking adjunctive mucosal protection, and gut lining repair protocols in functional medicine.
What Is Zinc Carnosine?
Zinc carnosine (marketed under the brand name PepZin GI) is a chelated compound combining zinc with L-carnosine in a 1:1 molar ratio. It’s not simply “zinc plus carnosine” taken separately – the chelation creates a distinct compound that behaves differently from either ingredient alone.
The key property is slow dissociation in gastric juice. Regular zinc supplements pass through the stomach quickly. Zinc carnosine adheres to ulcerated and damaged mucosal tissue and dissociates gradually, releasing zinc and carnosine directly at sites that need repair. This targeted delivery is the foundation of its clinical utility.
The Clinical Evidence
Japanese Multicenter Approval Trials
Zinc carnosine was approved as a prescription drug for gastric ulcers in Japan (marketed as Promac) based on multicenter clinical trials showing healing rates exceeding 90% after 8 weeks of treatment. These trials compared zinc carnosine to established anti-ulcer medications and found comparable efficacy. The Japanese approval process is rigorous, and Promac has remained in clinical use for decades – an important signal of real-world confidence in the compound.
The Indomethacin Challenge Study (Gut, 2007)
This is the study that made zinc carnosine notable in the Western supplement world. In a double-blind, randomized, placebo-controlled trial by Mahmood et al.:
- Healthy volunteers were given indomethacin – an NSAID that reliably damages both the stomach and small intestinal lining
- The zinc carnosine group showed a 75% reduction in gastric injury markers compared to placebo
- Small intestinal injury was reduced by approximately 50%
- The placebo group experienced a threefold increase in gut permeability; the zinc carnosine group did not
This study is significant because it used a controlled human challenge model – not just observational data or animal research. The indomethacin model is a validated, reproducible way to produce measurable gastric injury in humans, making this a genuine demonstration of protective effect.
How Zinc Carnosine Works: The Mechanisms
Multiple complementary pathways contribute to its efficacy:
- Physical adhesion to damaged tissue – the compound preferentially binds to ulcerated and inflamed mucosal sites, concentrating the active components where healing is needed
- Mucus stimulation – promotes mucus secretion by goblet cells, thickening the protective layer over the gastric epithelium
- Anti-inflammatory effects – reduces pro-inflammatory cytokines (IL-8, TNF-?) at the mucosal level, limiting secondary inflammatory damage
- Antioxidant protection – scavenges reactive oxygen species generated during mucosal injury, particularly relevant during NSAID use and H. pylori infection
- Cell migration support – promotes the migration of epithelial cells to cover and repair damaged areas, accelerating the wound-healing process
- Heat shock protein induction – some research suggests zinc carnosine induces gastroprotective heat shock proteins in gastric epithelial cells
Dosage and Timing
The standard clinical dose is 75 mg of zinc carnosine twice daily, typically taken on an empty stomach or between meals to maximize time in contact with the gastric mucosa. This is the dose used in most clinical research, including the Mahmood 2007 study.
Each 75 mg of zinc carnosine delivers approximately 16 mg of elemental zinc, for a total of roughly 32 mg daily from zinc carnosine alone. This is important:
- The tolerable upper intake level (UL) for zinc is 40 mg/day for adults
- If you also take a multivitamin with zinc, factor in that zinc when calculating total daily intake
- Long-term zinc above the UL can cause copper deficiency – if using zinc carnosine long-term, consider a small copper supplement (1-2 mg/day) or monitor
Who This Is Best For
Zinc carnosine makes the most clinical sense for:
- Regular NSAID users (ibuprofen, naproxen, aspirin) seeking gastric protection
- People with a history of gastric ulcers looking for maintenance support alongside medical care
- Those with mild gastritis or chronic stomach discomfort where H. pylori has been ruled out by testing
- Anyone on a gut-repair protocol under practitioner guidance – zinc carnosine pairs logically with L-glutamine and slippery elm in integrative approaches
- Athletes using high-dose NSAIDs for training recovery
Who Should Be Cautious
- People with copper deficiency or at risk for it – long-term high-dose zinc supplementation depletes copper; this is a real clinical concern, not theoretical
- Those already on multiple zinc-containing supplements – watch total elemental zinc from all sources
- People with active bleeding ulcers – this is a medical emergency requiring immediate care, not a supplement situation
- Those on certain antibiotics – zinc can interfere with absorption of fluoroquinolones and tetracyclines; separate by 2+ hours
Honest Limitations
Zinc carnosine is one of the better-supported natural gastric compounds, but honest caveats apply:
- The Japanese approval trials are not all available in English, and industry sponsorship of some trials introduces potential bias
- The key Mahmood 2007 study used an induced-injury model, not spontaneous ulcers – it demonstrates protection under challenge conditions, not necessarily in all gastric contexts
- It is not a proven replacement for PPIs or triple antibiotic therapy in H. pylori-positive disease
- Most Western studies are relatively small; larger independent replication is limited
These caveats don’t undermine the core evidence – they contextualize it. Zinc carnosine has legitimate clinical use, particularly for NSAID gastroprotection and gut-repair protocols, but it should complement rather than replace medical management for serious gastric disease.
What to Look For When Buying
- Branded PepZin GI (from Hamari Chemicals, Japan) – this is the form used in clinical studies; off-brand zinc carnosine may not match the manufacturing specifications
- At least 75 mg per capsule – some products underdose; check the label carefully
- Third-party testing for purity and label accuracy
- Avoid formulas that combine zinc carnosine with large amounts of other coating agents – these may interfere with its adhesion mechanism
This content is for informational purposes only. If you have or suspect a gastric ulcer, see a healthcare provider for proper diagnosis and treatment before relying on supplements.
FAQ
Is PepZin GI effective for gastric ulcers?
Yes – PepZin GI (zinc carnosine) has genuine clinical evidence for gastric ulcer treatment. Japanese multicenter RCTs leading to the pharmaceutical Promac approval demonstrated significant ulcer healing rates. The Mahmood et al. Gut 2007 study showed protection against NSAID-induced gut permeability increases in healthy volunteers. It is one of the most clinically supported nutraceutical compounds for gastric mucosal protection.
What is the difference between zinc carnosine and regular zinc?
Regular zinc and carnosine are both bioactive alone, but the chelated zinc carnosine complex behaves differently: it remains intact in the gastric environment and adheres to damaged mucosa with much longer contact time than either component separately. This extended mucosal adhesion is the primary pharmacological advantage. Regular zinc supplements (glycinate, citrate) provide systemic zinc but without ZnC’s targeted gastric mucosal residence.
How long should I take zinc carnosine?
Japanese clinical trials used 150 mg/day (75 mg BID) for 8 weeks for gastric ulcer treatment. For ongoing mucosal protection (NSAID users, chronic gastritis, gut lining support), lower doses (75-150 mg/day) can be used indefinitely with appropriate monitoring. At 150 mg/day (32 mg elemental zinc), supplement copper (2 mg/day) to prevent zinc-induced copper deficiency with long-term use.
Does zinc carnosine interact with medications?
Zinc can reduce absorption of certain medications: fluoroquinolone antibiotics, tetracyclines, and bisphosphonates. Take zinc carnosine at least 2 hours apart from these medications. Zinc also slightly reduces iron absorption – take iron supplements separately. Zinc carnosine in supplement doses does not have significant interactions with PPIs or H2 blockers (it can be used alongside them as a complementary mucosal protectant).
Related Articles
- Slippery Elm for Stomach Issues: Traditional Remedy
- Best Supplements for Stomach Lining Support in 2026
- Postbiotic Blends for Gut Barrier Repair
- Gut Supplement Stack for Beginners
- Best Butyrate and Tributyrin Supplements 2026
Sources
- Clinical, Immunological and Microbiological Improvements With Zinc-Coated Healing Abutments During the Healing Phase. International dental journal. 2026. PMID: 41653836.
- The role of Zinc L-Carnosine in the prevention and treatment of gastrointestinal mucosal disease in humans: a review. Clinics and research in hepatology and gastroenterology. 2022. PMID: 35659631.
- The association between micronutrient status and clinical outcomes in children with cancer undergoing treatment: A systematic review and meta-analysis. Clinical nutrition (Edinburgh, Scotland). 2026. PMID: 41967219.
- Short-Term Clinical Effects After Switching From Zinc Acetate Hydrate to Zinc Histidine Hydrate in Patients With Chronic Liver Disease. Hepatology research : the official journal of the Japan Society of Hepatology. 2026. PMID: 41999144.
- Gastroprotective Effect of Quercetin and Misoprostol in Ethanol-Induced Gastric Ulcer (2024)
Leave a Reply